3.8 Article

Synergistic Osteogenesis of Biocompatible Reduced Graphene Oxide with Methyl Vanillate in BMSCs

Journal

ACS BIOMATERIALS SCIENCE & ENGINEERING
Volume 5, Issue 4, Pages 1920-1936

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.8b01264

Keywords

methyl vanillate; graphene oxide; Wnt/beta-catenin; endocytosis

Funding

  1. National Natural Science Foundation of China [81620108006, 31500787, 81430012, 51703127, 81801006, 31600777]
  2. National Key Research and Development Program of China [2016YFC1102900]
  3. Young Elite Scientist Sponsorship Program, CAST [2017QNRC001]
  4. Shanghai Sailing Program [16YF1406600]
  5. Interdisciplinary Program of Shanghai Jiao Tong University [YG2015ZD06]

Ask authors/readers for more resources

Methyl vanillate (MV), a recently characterized small molecule, can promote the Wnt/beta-catenin signaling pathway and induce osteoblast differentiation both in vitro and in vivo. On the other hand, graphene-based materials have been introduced into the field of biomedical sciences in the past decade, and graphene oxide (GO), which serves as an efficient nanocarrier for drug delivery, has attracted great attention for its biomedical applications in tissue engineering. This study aimed to develop a biocompatible gelatin-reduced graphene oxide (GOG) for MV delivery so as to realize the effective osteogenesis for bone repair. First, GOG was prepared, and its morphology as well as properties were then characterized using scanning electron microscope (SEM), transmission electron microscopy (TEM), atomic force microscope (AFM), Raman spectroscopy, X-ray photoelectron spectroscopy (XPS), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and thermal gravimetric analysis (TGA), respectively. In addition, the endocytosis of GOG in bone marrow stromal cells (BMSCs) was also investigated with the treatment of Rhodamine 6G (R6G)-labeled GOG. Our results found that GOG could be easily absorbed by cells and was distributed in both nucleus and cytoplasm, thus suggesting the favorable biocompatibility of GOG. Moreover, the effect of MV on osteogenesis was also tested, the results of which indicated that MV could promote BMSC osteogenesis in a concentration-dependent manner, and significant enhancement could be achieved at the concentration of 1 mu g/mL. In addition, the complex containing different concentrations of GOG and an optimal concentration of MV was used to investigate the synergistic effect between GOG and MV on pro-osteogenesis. The results revealed that the weight ratio of MV/GOG of 1:1000 could attain remarkably enhanced osteoinduction in BMSCs, as evaluated by alkaline phosphatase (ALP) assay, alizarin red S (ARS) staining, immunofluorescence staining, and gene expression of related osteogenic markers. Taken together, these data had provided strong evidence that the complex of MV and GOG could induce osteogenesis, which was promising for bone tissue engineering.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available